111 related articles for article (PubMed ID: 7883225)
41. High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis.
Scates DK; Venitt S; Phillips RK; Spigelman AD
Gut; 1995 Jun; 36(6):918-21. PubMed ID: 7615284
[TBL] [Abstract][Full Text] [Related]
42. Rate of caffeine metabolism and risk of spontaneous abortion.
Fenster L; Quale C; Hiatt RA; Wilson M; Windham GC; Benowitz NL
Am J Epidemiol; 1998 Mar; 147(5):503-10. PubMed ID: 9525538
[TBL] [Abstract][Full Text] [Related]
43. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans.
Sinha R; Rothman N; Brown ED; Mark SD; Hoover RN; Caporaso NE; Levander OA; Knize MG; Lang NP; Kadlubar FF
Cancer Res; 1994 Dec; 54(23):6154-9. PubMed ID: 7954461
[TBL] [Abstract][Full Text] [Related]
44. Childbirth after surgery for familial adenomatous polyposis in Japan.
Kobayashi H; Ishida H; Ueno H; Hinoi T; Inoue Y; Ishida F; Kanemitsu Y; Konishi T; Yamaguchi T; Tomita N; Matsubara N; Watanabe T; Sugihara K
Surg Today; 2017 Feb; 47(2):233-237. PubMed ID: 27357052
[TBL] [Abstract][Full Text] [Related]
45. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis.
Nieuwenhuis MH; De Vos Tot Nederveen Cappel W; Botma A; Nagengast FM; Kleibeuker JH; Mathus-Vliegen EM; Dekker E; Dees J; Wijnen J; Vasen HF
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):215-9. PubMed ID: 18237870
[TBL] [Abstract][Full Text] [Related]
46. Association between the age and the development of colorectal cancer in patients with familial adenomatous polyposis: a multi-institutional study.
Kobayashi H; Ishida H; Ueno H; Hinoi T; Inoue Y; Ishida F; Kanemitsu Y; Konishi T; Yamaguchi T; Tomita N; Matsubara N; Watanabe T; Sugihara K
Surg Today; 2017 Apr; 47(4):470-475. PubMed ID: 27506752
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
48. Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeine.
Bloomer JC; Clarke SE; Chenery RJ
Xenobiotica; 1995 Sep; 25(9):917-27. PubMed ID: 8553685
[TBL] [Abstract][Full Text] [Related]
49. Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans.
Kadlubar FF
Drug Metab Rev; 1994; 26(1-2):37-46. PubMed ID: 8082575
[No Abstract] [Full Text] [Related]
50. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
51. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
[TBL] [Abstract][Full Text] [Related]
52. Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone-deficient children.
Mayayo-Sinués E; Fanlo A; Sinués B; Mayayo E; Labarta JI; García de Jalón A; Ferrández-Longás A
Eur J Clin Pharmacol; 2006 Feb; 62(2):123-7. PubMed ID: 16408225
[TBL] [Abstract][Full Text] [Related]
53. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
Kadmon M; Möslein G; Buhr HJ; Herfarth C
Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
[TBL] [Abstract][Full Text] [Related]
54. Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children.
Kennedy MJ; Abdel-Rahman SM; Kashuba AD; Leeder JS
J Clin Pharmacol; 2004 Jul; 44(7):708-14. PubMed ID: 15199075
[TBL] [Abstract][Full Text] [Related]
55. Colorectal Adenomatous Polyposis: Heterogeneity of Susceptibility Gene Mutations and Phenotypes in a Cohort of Italian Patients.
Marabelli M; Molinaro V; Abou Khouzam R; Berrino E; Panero M; Balsamo A; Venesio T; Ranzani GN
Genet Test Mol Biomarkers; 2016 Dec; 20(12):777-785. PubMed ID: 27705013
[TBL] [Abstract][Full Text] [Related]
56. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
[TBL] [Abstract][Full Text] [Related]
57. Endoscopic management of patients with familial adenomatous polyposis (FAP) following a colectomy.
Saurin JC; Napoleon B; Gay G; Ponchon T; Arpurt JP; Boustiere C; Boyer J; Canard JM; Dalbies PA; Escourrou J; Greff M; Lapuelle J; Laugier R; Letard JC; Marchetti B; Palazzo L; Sautereau D; Vedrenne B;
Endoscopy; 2005 May; 37(5):499-501. PubMed ID: 15844037
[No Abstract] [Full Text] [Related]
58. [Familial adenomatous polyposis (FAP): integration of clinical and genetic parameters in the screening of subjects at risk. A one-family example].
Chautems R; Givel JC
Swiss Surg; 1996; 2(5):196-200. PubMed ID: 8963844
[TBL] [Abstract][Full Text] [Related]
59. CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine.
Carrillo JA; Benitez J
Br J Clin Pharmacol; 1996 Jun; 41(6):605-8. PubMed ID: 8799528
[TBL] [Abstract][Full Text] [Related]
60. Altered xanthine oxidase and N-acetyltransferase activity in obese children.
Chiney MS; Schwarzenberg SJ; Johnson LA
Br J Clin Pharmacol; 2011 Jul; 72(1):109-15. PubMed ID: 21382071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
